COMPUTER MODELING OF AN ATP-BINDING PROTEIN

ATP 结合蛋白的计算机建模

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The origins of water-soluble proteins appear to be considerably more difficult to identify than the origins of membrane-bound proteins. Most transmembrane proteins, even those that are functionally and structurally complex, are built of a small number of structural elements that are shared across protein families. Moreover, there are simple, natural or synthetic models consisting of the same elements that can perform essential membrane-related functions. This is not the case with cytoplasmic proteins. In contemporary cells, they are usually quite large by protobiological standards, but in contrast to membrane proteins they cannot be significantly reduced in size without loss of activity. Using a novel in vitro technique, Keefe and Szostak selected ATP-binding proteins from six trillion random polypeptides. They found four new protein families, each containing proteins with highly similar amino acid sequences that were unrelated to each other or to anything found in the current protein databases. The frequency of finding ATP-binding proteins appears to be similar to the frequency of finding ATP-binding ribozymes. Proteins from one family have been characterized in fair detail. The originally selected protein contained 80 amino acids but deletion studies revealed that the minimal binding unit is less than 50 amino acids long and, thus, is the smallest known ATP-binding protein. The proteins are highly selective towards ATP and its close analog, adenosine diphosphate (ADP), as they bind neither guanosine triphosphate (GTP) nor cyclic AMP. However, their sequences do not contain any already identified ATP-binding motifs. To function, they require zinc ions and contain four conserved cysteine residues. More recently, the high resolution, three-dimensional structure of a protein from the family was solved using X-ray crystallography. As all biological, water-soluble proteins, this structure has a hydrophobic core, but exhibits a novel fold. It consists of a three-stranded antiparallel beta-sheet and two nonadjacent alpha-helices. ADP is stabilized in the binding pocket by stacking interactions with phenylalanine and tyrosine residues and by hydrogen bonds to several side chains in the protein. Selectivity of binding appears to be insured by hydrogen bonds between the N1, N3 and N6 of adenine and methianine-45 and glycine-63. A zinc ion is coordinated by the conserved cysteines in a region not adjacent to the binding pocket. The ATP-binding protein is a very interesting protobiological model because it is the first example of a simple, functional protein that has not been a subject of long evolutionary optimization. However, its folding pattern may be evolutionarily deficient. For example, it may not have the capability to acquire new specificity through mutations. We propose to examine the protein from this point of view and, if necessary, redesign its sequence in an attempt to eliminate the deficiencies without altering the fold. If this task were successful it would lead to the creation of a novel fold that appears to be suitable for evolution, thus providing an empirical argument supporting an "evolutionary accident" hypothesis of the origin of enzymes. If we found that the sequence could not be appropriately redesigned it would suggest that the fold, even if it were present among protobiological proteins, was not likely to survive subsequent evolutionary pressures. Although it would be clearly premature to draw conclusions from a single negative example, this result would hint that a hypothesis about evolutionary pruning of protein structures is worth serious considerations. In either case, we would gain an understanding how to construct and identify good candidate models for evolutionarily viable protobiological enzymes.
该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金, 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说,它不一定是研究者的机构。 水溶性蛋白质的起源似乎比膜结合蛋白质的起源更难鉴定。大多数跨膜蛋白,即使是那些功能和结构复杂的跨膜蛋白,也是由蛋白质家族共享的少量结构元件组成的。此外,还有由相同元素组成的简单、天然或合成模型,可以执行基本的膜相关功能。细胞质蛋白的情况并非如此。在当代细胞中,按照原始生物学标准,它们通常相当大,但与膜蛋白相比,它们不能在不丧失活性的情况下显着减小尺寸。 Keefe 和 Szostak 使用一种新颖的体外技术从 6 万亿个随机多肽中选择了 ATP 结合蛋白。他们发现了四个新的蛋白质家族,每个家族都含有氨基酸序列高度相似的蛋白质,这些蛋白质彼此无关,也与当前蛋白质数据库中发现的任何内容无关。发现 ATP 结合蛋白的频率似乎 类似于发现 ATP 结合核酶的频率。 来自一个家族的蛋白质已得到相当详细的表征。最初选择的蛋白质含有 80 个氨基酸,但删除研究表明最小结合单元的长度小于 50 个氨基酸,因此是已知最小的 ATP 结合蛋白。这些蛋白质对 ATP 及其 紧密类似物二磷酸腺苷 (ADP),因为它们既不结合三磷酸鸟苷 (GTP) 也不结合环 AMP。然而,它们的序列不包含任何已鉴定的 ATP 结合基序。为了发挥作用,它们需要锌离子并含有四个保守的半胱氨酸残基。最近,使用 X 射线晶体学解析了该家族蛋白质的高分辨率三维结构。与所有生物水溶性蛋白质一样,该结构具有疏水核心,但表现出新颖的折叠。它由三股线组成 反平行的β-折叠和两个不相邻的α-螺旋。 ADP稳定在 通过与苯丙氨酸和酪氨酸残基的堆积相互作用以及通过氢键与蛋白质中的几个侧链形成结合袋。结合的选择性似乎是由腺嘌呤、甲氨酸-45 和甘氨酸-63 的 N1、N3 和 N6 之间的氢键确保的。锌离子由不邻近结合袋的区域中的保守半胱氨酸配位。 ATP 结合蛋白是一个非常有趣的原始生物学模型,因为它是第一个没有经过长期进化优化的简单功能蛋白的例子。然而,它的折叠模式可能在进化上存在缺陷。例如,它可能没有能力通过突变获得新的特异性。我们建议从这个角度检查蛋白质,并在必要时重新设计其序列,以试图在不改变折叠的情况下消除缺陷。如果这项任务成功,它将导致创建一种似乎适合进化的新颖折叠,从而提供支持的经验论据 酶起源的“进化偶然”假说。如果我们发现该序列无法适当地重新设计,则表明该折叠即使存在于原生生物蛋白质中,也不太可能在随后的进化压力中幸存下来。尽管从单个反面例子中得出结论显然还为时过早,但这一结果暗示有关蛋白质结构进化修剪的假设值得认真考虑。无论哪种情况,我们都将了解如何构建和识别进化上可行的原生物酶的良好候选模型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREW POHORILLE其他文献

ANDREW POHORILLE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREW POHORILLE', 18)}}的其他基金

COMPUTER MODELING OF THE ANTIAMOEBIN ION CHANNEL
抗阿米巴离子通道的计算机建模
  • 批准号:
    8363639
  • 财政年份:
    2011
  • 资助金额:
    $ 0.89万
  • 项目类别:
COMPUTER MODELING OF AN ATP-BINDING PROTEIN
ATP 结合蛋白的计算机建模
  • 批准号:
    8170538
  • 财政年份:
    2010
  • 资助金额:
    $ 0.89万
  • 项目类别:
COMPUTER SIMULATION OF THE INFLUENZA M2 CHANNEL
M2 流感通道的计算机模拟
  • 批准号:
    7723515
  • 财政年份:
    2008
  • 资助金额:
    $ 0.89万
  • 项目类别:
COMPUTER MODELING OF AN ATP-BINDING PROTEIN
ATP 结合蛋白的计算机建模
  • 批准号:
    7723521
  • 财政年份:
    2008
  • 资助金额:
    $ 0.89万
  • 项目类别:
COMPUTER SIMULATION OF THE INFLUENZA M2 CHANNEL
M2 流感通道的计算机模拟
  • 批准号:
    7367788
  • 财政年份:
    2006
  • 资助金额:
    $ 0.89万
  • 项目类别:
ASSOCIATION OF PEPTIDES IN MEMBRANES
膜中肽的缔合
  • 批准号:
    7367745
  • 财政年份:
    2006
  • 资助金额:
    $ 0.89万
  • 项目类别:
ASSOCIATION OF PEPTIDES IN MEMBRANES
膜中肽的缔合
  • 批准号:
    7180231
  • 财政年份:
    2005
  • 资助金额:
    $ 0.89万
  • 项目类别:
ASSOCIATION OF PEPTIDES IN MEMBRANES
膜中肽的缔合
  • 批准号:
    6976103
  • 财政年份:
    2004
  • 资助金额:
    $ 0.89万
  • 项目类别:
ION CHANNEL PROTEINS IN MEMBRANES
膜中的离子通道蛋白
  • 批准号:
    6456770
  • 财政年份:
    2001
  • 资助金额:
    $ 0.89万
  • 项目类别:
ION CHANNEL PROTEINS IN MEMBRANES
膜中的离子通道蛋白
  • 批准号:
    6347932
  • 财政年份:
    2000
  • 资助金额:
    $ 0.89万
  • 项目类别:

相似国自然基金

N6-腺嘌呤甲基化修饰调控玉米抗旱性的分子机制研究
  • 批准号:
    32370633
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于新型脂质多聚复合物的腺嘌呤碱基编辑系统对高草酸尿症的基因治疗研究
  • 批准号:
    52373134
  • 批准年份:
    2023
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
烟酰胺腺嘌呤二核苷酸从头合成新途径的发现与解析
  • 批准号:
    32370058
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
新一代精准、安全、适用范围更广的腺嘌呤碱基编辑器的开发及其在基因治疗中的应用研究
  • 批准号:
    32371535
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
超亲和识别体的人工进化与全基因DNA/RNA腺嘌呤甲基化测序新方法
  • 批准号:
    22234008
  • 批准年份:
    2022
  • 资助金额:
    280 万元
  • 项目类别:
    重点项目

相似海外基金

Stem Cell Dysfunction in Aged Skeletal Muscle
老年骨骼肌干细胞功能障碍
  • 批准号:
    10736449
  • 财政年份:
    2023
  • 资助金额:
    $ 0.89万
  • 项目类别:
Chemical Biology-Based Tools to Uncover the Function of PARP16 in cancer
基于化学生物学的工具揭示 PARP16 在癌症中的功能
  • 批准号:
    10750279
  • 财政年份:
    2023
  • 资助金额:
    $ 0.89万
  • 项目类别:
Identifying the targets of virus-induced PARPs during SARS-CoV-2 infection
识别 SARS-CoV-2 感染期间病毒诱导的 PARP 的靶标
  • 批准号:
    10573499
  • 财政年份:
    2022
  • 资助金额:
    $ 0.89万
  • 项目类别:
Characterization of a novel spinal astrocyte-neuron signaling system in chronic pain
慢性疼痛中新型脊髓星形胶质细胞-神经元信号系统的表征
  • 批准号:
    10216697
  • 财政年份:
    2021
  • 资助金额:
    $ 0.89万
  • 项目类别:
Characterization of a novel spinal astrocyte-neuron signaling system in chronic pain
慢性疼痛中新型脊髓星形胶质细胞-神经元信号系统的表征
  • 批准号:
    10382365
  • 财政年份:
    2021
  • 资助金额:
    $ 0.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了